On November 18, the World Health Organization and York University organized a virtual event to formally announce that the Global Strategy Lab was designated as a WHO Collaborating Centre on Global Governance of Antimicrobial Resistance (AMR). This follows the original designation by the WHO in November 2019.
In the event, dignitaries from the WHO, the Canadian federal government, York University, the wider world of AMR research and GSL spoke to the significance of having a WHO Collaborating Centre on Global Governance of AMR at York University.
York University President Rhonda Lenton spoke to the university’s tradition as a research institution and lauded GSL’s longstanding record of conducting research to inform policy for the pressing challenges of our time.
Chief Public Health Officer of Canada Dr. Theresa Tam, who despite a full calendar of managing Canada’s response to a global pandemic found time to attend the event, stated Canada’s continued commitment to be a leader in the fight against antimicrobial resistance. She further affirmed that global collaboration was the most effective way to tackle complex public health challenges like AMR.
After the CPHO, Director Steven Hoffman and Managing Director Susan Rogers Van Katwyk introduced the mission of the WHO Collaborating Centre to the event’s attendees.
The announcement event concluded with an expert panel consisting of WHO Special Advisor to the Secretary-General, Peter A. Singer, Master of Trinity College Oxford and UK envoy for AMR, Dame Sally Davies and Steven Hoffman answering a wide variety of questions surrounding the topic of AMR.
The event was mc-ed by York University’s Dean of the Health faculty, Prof. Paul McDonald
To learn more about our collaborating centre, visit our website.
If you’d like to rewatch the event, click on the video on the right.
Previous